Renaissance Technologies - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 5 filers reported holding REVANCE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,047
-61.6%
178,500
-15.2%
0.00%
-62.5%
Q2 2023$5,328
-99.9%
210,517
-55.5%
0.01%
+14.3%
Q1 2020$6,996,000
-36.4%
472,700
-30.2%
0.01%
-12.5%
Q4 2019$10,995,000
-3.5%
677,473
-22.7%
0.01%
-20.0%
Q3 2019$11,393,000
-34.0%
876,373
-34.2%
0.01%
-33.3%
Q2 2019$17,263,000
+21.4%
1,330,973
+47.5%
0.02%
+15.4%
Q1 2019$14,217,000
+23.5%
902,073
+57.7%
0.01%0.0%
Q4 2018$11,512,000
+162.5%
571,873
+224.1%
0.01%
+160.0%
Q3 2018$4,385,000
-60.4%
176,454
-54.2%
0.01%
-16.7%
Q2 2018$11,073,000
+139.8%
385,100
+156.9%
0.01%
+20.0%
Q1 2018$4,617,000
+46.9%
149,900
+70.4%
0.01%
+66.7%
Q4 2017$3,144,000
+43.0%
87,956
+10.2%
0.00%0.0%
Q3 2017$2,198,000
-24.6%
79,792
-27.7%
0.00%
-25.0%
Q2 2017$2,914,000
-60.5%
110,373
-48.9%
0.00%
-75.0%
Q4 2015$7,375,000
+183.2%
215,900
+146.7%
0.02%
+166.7%
Q3 2015$2,604,000
-36.6%
87,500
-31.9%
0.01%
-33.3%
Q2 2015$4,109,000
+203.0%
128,500
+96.5%
0.01%
+200.0%
Q1 2015$1,356,00065,4090.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
NovaQuest Capital Management, L.L.C. 1,558,426$42,779,00061.17%
Essex Woodlands Management, Inc. 3,342,047$91,739,00021.30%
Sio Capital Management, LLC 101,292$2,780,0001.54%
Fosun International Ltd 472,532$12,971,0000.66%
Rhenman & Partners Asset Management AB 203,181$5,577,0000.57%
ArrowMark Colorado Holdings LLC 1,804,275$49,527,0000.46%
ESSEX INVESTMENT MANAGEMENT CO LLC 87,355$2,398,0000.30%
FOX RUN MANAGEMENT, L.L.C. 18,477$507,0000.16%
Phoenix Investment Adviser LLC 2,400$66,0000.12%
Quinn Opportunity Partners LLC 33,100$909,0000.12%
View complete list of REVANCE THERAPEUTICS INC shareholders